“Valeant says it will eliminate as much as 15 per cent of its work force and move Bausch + Lomb's headquarters to New Jersey as part of its $8.7 billion acquisition,” reports Canadian Yahoo! News. “In a letter to workers, Valeant says that after the deal closes, it will eliminate between 10 per cent and 15 per cent of positions companywide. That works out to between 1,850 and 2,775 people. The Canadian drugmaker says it will remain based in Quebec, but it will move Bausch + Lomb's Rochester, N.Y. headquarters to New Jersey.” Read more.
Showing posts with label Bausch and Lomb North American Vision Care. Show all posts
Showing posts with label Bausch and Lomb North American Vision Care. Show all posts
Monday, July 29, 2013
Thursday, May 17, 2012
eInk Devices, like the Traditional Kindle, Better for Eyes
"According to Dr. Michael Pier, O.D., Director
of Professional Relations for the Bausch & Lomb North American
Vision Care, the drawbacks of the bland and colorless interfaces typical
to grayscale eInk readers are outweighed by their ocular advantages," reports Tablet PC Review. "'The total benefit of eInk is the reduction of glare,' says Pier. 'Glare
affects your ability to see the contrasts between the letters and the
background, and this is virtually eliminated by eInk. The better the
contrast, the easier it is on the eyes. Contrast allows us to grab focus
faster, because we’re not trying to interpret what might appear as a
blur on the edges of letters.' In other words, eInk devices like the traditional Kindle eReader are easier to view with a glaring sun or light overhead." Read more.
Subscribe to:
Posts (Atom)